May 25 (Reuters) - MGC Pharmaceuticals Ltd MXC.AX :
* FDA approval granted and first us distribution deal signed MXC.AX
* Has received formal US food and drug administration (FDA) approval of its
first 16 cannabidiol (cbd) based anti-ageing cosmetic products
* Says MGC derma will now pursue exclusive agreements with strategic
distribution partners in key US states
* Discussions are underway to extend -agreement to include jv's focusing on
genetics, growing and medicinal cannabis value add products
* Company also currently has applications pending for similar approvals in
Canada and Australia
* Says FDA approval means that the 16 MGC derma cbd based products can be
imported and sold throughout the whole of the USA
* Source text for Eikon ID:nASX6DH1ZF
*